J
James B. Young
Researcher at Northwestern University
Publications - 293
Citations - 25977
James B. Young is an academic researcher from Northwestern University. The author has contributed to research in topics: Heart failure & Sympathetic nervous system. The author has an hindex of 67, co-authored 291 publications receiving 24669 citations. Previous affiliations of James B. Young include University of Southampton & Dana Corporation.
Papers
More filters
Journal ArticleDOI
Contemporary Definitions and Classification of the Cardiomyopathies An American Heart Association Scientific Statement From the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention
Barry J. Maron,Jeffrey A. Towbin,Gaetano Thiene,Charles Antzelevitch,Domenico Corrado,Donna K. Arnett,Arthur J. Moss,Christine E. Seidman,James B. Young +8 more
TL;DR: The present classification scheme recognizes the rapid evolution of molecular genetics in cardiology, as well as the introduction of several recently described diseases, and is unique in that it incorporates ion channelopathies as a primary cardiomyopathy.
Journal ArticleDOI
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals
Hertzel C. Gerstein,Johannes F.E. Mann,Qilong Yi,Bernard Zinman,Sean F. Dinneen,Byron J. Hoogwerf,Jean Pierre Hallé,James B. Young,Andrew Rashkow,Carol Joyce,Shah Nawaz,Salim Yusuf +11 more
TL;DR: The results indicate that any degree of albuminuria is a risk factor for CV events in individuals with or without DM; the risk increases with the ACR, starting well below the microalbuminuria cutoff.
Journal ArticleDOI
Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man
John W. Rowe,James B. Young,Kenneth L. Minaker,Arthur L Stevens,Johanna A. Pallotta,Lewis Landsberg +5 more
TL;DR: Insulin infusion increases sympathetic nervous system activity in the absence of changes in blood glucose in nonobese young men using glucose clamp techniques.
Journal Article
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial
Journal ArticleDOI
Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart Failure
Mihai Gheorghiade,William T. Abraham,Nancy M. Albert,Barry H. Greenberg,Christopher M. O'Connor,Lilin She,Wendy Gattis Stough,Wendy Gattis Stough,Clyde W. Yancy,Clyde W. Yancy,James B. Young,Gregg C. Fonarow +11 more
TL;DR: Systolic blood pressure is an independent predictor of morbidity and mortality in patients with heart failure with either reduced or relatively preserved systolic function and low SBP at hospital admission identifies patients who have a poor prognosis despite medical therapy.